<VariationArchive RecordType="classified" VariationID="549711" VariationName="NM_006412.4(AGPAT2):c.513del (p.Glu172fs)" VariationType="Deletion" Accession="VCV000549711" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2019-02-17" MostRecentSubmission="2019-02-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="540479" VariationID="549711">
      <GeneList>
        <Gene Symbol="AGPAT2" FullName="1-acylglycerol-3-phosphate O-acyltransferase 2" GeneID="10555" HGNC_ID="HGNC:325" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="136673143" stop="136687457" display_start="136673143" display_stop="136687457" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="139567594" stop="139581910" display_start="139567594" display_stop="139581910" Strand="-" />
          </Location>
          <OMIM>603100</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006412.4(AGPAT2):c.513del (p.Glu172fs)</Name>
      <CanonicalSPDI>NC_000009.12:136676659:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="136676660" stop="136676660" display_start="136676660" display_stop="136676660" variantLength="1" positionVCF="136676659" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="139571112" stop="139571112" display_start="139571112" display_stop="139571112" variantLength="1" positionVCF="139571111" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E172fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.139571114del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.139571114del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.136676662del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.136676662del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008090.1" sequenceAccession="NG_008090" sequenceVersion="1" change="g.15800del">
            <Expression>NG_008090.1:g.15800del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006412.4" sequenceAccession="NM_006412" sequenceVersion="4" change="c.513del" MANESelect="true">
            <Expression>NM_006412.4:c.513del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006403.2" sequenceAccession="NP_006403" sequenceVersion="2" change="p.Glu172fs">
            <Expression>NP_006403.2:p.Glu172fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001012727.2" sequenceAccession="NM_001012727" sequenceVersion="2" change="c.492+301del">
            <Expression>NM_001012727.2:c.492+301del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1564290914" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006412.4(AGPAT2):c.513del (p.Glu172fs) AND Congenital generalized lipodystrophy type 1" Accession="RCV000754914" Version="2">
        <ClassifiedConditionList TraitSetID="1835">
          <ClassifiedCondition DB="MedGen" ID="C1720862">Congenital generalized lipodystrophy type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-05-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-05-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-02-17" MostRecentSubmission="2019-02-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1835" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5410" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BRUNZELL SYNDROME, AGPAT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="608594" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital generalized lipodystrophy type 1</ElementValue>
                <XRef ID="Congenital+Generalized+Lipodystrophy+Type+1/1829" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012071" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CGL1</ElementValue>
                <XRef Type="MIM" ID="608594" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BSCL1</ElementValue>
                <XRef Type="MIM" ID="608594" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality.</Attribute>
                <XRef ID="NBK1212" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="84" />
                <XRef ID="84" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="C1720862" DB="MedGen" />
              <XRef ID="MONDO:0012071" DB="MONDO" />
              <XRef Type="MIM" ID="608594" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1537725" SubmissionDate="2018-05-11" DateLastUpdated="2019-02-17" DateCreated="2019-02-17">
        <ClinVarSubmissionID localKey="NM_006412.3:c.513delC|OMIM:608594" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000787615" DateUpdated="2019-02-17" DateCreated="2019-02-17" Type="SCV" Version="1" SubmitterName="Laboratory of Metabolic Disorders, Peking University First Hospital" OrgID="505591" OrganizationCategory="laboratory" OrgAbbreviation="PKU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGPAT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006412.3:c.513delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608594" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4023379</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1537725" TraitType="Disease" MappingType="XRef" MappingValue="608594" MappingRef="OMIM">
        <MedGen CUI="C1720862" Name="Congenital generalized lipodystrophy type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

